We've found
14,731
archived clinical trials in
Psychiatric
We've found
14,731
archived clinical trials in
Psychiatric
Assessing and Addressing Behaviors in Children With Hearing Loss
Updated: 12/31/1969
Assessing and Addressing Behaviors in Children With Hearing Loss
Status: Enrolling
Updated: 12/31/1969
Assessing and Addressing Behaviors in Children With Hearing Loss
Updated: 12/31/1969
Assessing and Addressing Behaviors in Children With Hearing Loss
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Assessing and Addressing Behaviors in Children With Hearing Loss
Updated: 12/31/1969
Assessing and Addressing Behaviors in Children With Hearing Loss
Status: Enrolling
Updated: 12/31/1969
Assessing and Addressing Behaviors in Children With Hearing Loss
Updated: 12/31/1969
Assessing and Addressing Behaviors in Children With Hearing Loss
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Theta-Burst Neuromodulation for PTSD
Updated: 12/31/1969
Pilot Testing of Theta-Burst Neuromodulation for Chronic PTSD
Status: Enrolling
Updated: 12/31/1969
Theta-Burst Neuromodulation for PTSD
Updated: 12/31/1969
Pilot Testing of Theta-Burst Neuromodulation for Chronic PTSD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial of Smoking Cessation Mobile Phone Program
Updated: 12/31/1969
Clinical Trial of Mobile-Based Intervention for Smoking Cessation
Status: Enrolling
Updated: 12/31/1969
Clinical Trial of Smoking Cessation Mobile Phone Program
Updated: 12/31/1969
Clinical Trial of Mobile-Based Intervention for Smoking Cessation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Virtual Reality for Phantom Limb Pain
Updated: 12/31/1969
Adapting Virtual Reality Technology for the Treatment of Phantom Limb Pain
Status: Enrolling
Updated: 12/31/1969
Virtual Reality for Phantom Limb Pain
Updated: 12/31/1969
Adapting Virtual Reality Technology for the Treatment of Phantom Limb Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Alcohol Drinking as a Vital Sign
Updated: 12/31/1969
Alcohol SBIRT Implementation in an HMO: Non-Physician Providers Vs Physicians
Status: Enrolling
Updated: 12/31/1969
Alcohol Drinking as a Vital Sign
Updated: 12/31/1969
Alcohol SBIRT Implementation in an HMO: Non-Physician Providers Vs Physicians
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Brief Intervention for OCD Fears
Updated: 12/31/1969
Brief Intervention for OCD Fears
Status: Enrolling
Updated: 12/31/1969
Brief Intervention for OCD Fears
Updated: 12/31/1969
Brief Intervention for OCD Fears
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Brief Intervention to Reduce Fear of Public Speaking
Updated: 12/31/1969
Brief Intervention to Reduce Fear of Public Speaking
Status: Enrolling
Updated: 12/31/1969
Brief Intervention to Reduce Fear of Public Speaking
Updated: 12/31/1969
Brief Intervention to Reduce Fear of Public Speaking
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers
Updated: 12/31/1969
A Behavioral and Functional Neuroimaging Study of Inhibitory Motor Control
Status: Enrolling
Updated: 12/31/1969
Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers
Updated: 12/31/1969
A Behavioral and Functional Neuroimaging Study of Inhibitory Motor Control
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Student Stress Levels and Management Through Meditation
Updated: 12/31/1969
Physical Therapist Doctoral Student Stress Levels and Management Through Meditation
Status: Enrolling
Updated: 12/31/1969
Student Stress Levels and Management Through Meditation
Updated: 12/31/1969
Physical Therapist Doctoral Student Stress Levels and Management Through Meditation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
Updated: 12/31/1969
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
Status: Enrolling
Updated: 12/31/1969
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
Updated: 12/31/1969
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
Updated: 12/31/1969
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
Status: Enrolling
Updated: 12/31/1969
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
Updated: 12/31/1969
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention
Updated: 12/31/1969
Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention
Status: Enrolling
Updated: 12/31/1969
Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention
Updated: 12/31/1969
Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
Updated: 12/31/1969
Assessing Changes in the Brain Melanocortin System and Sensory Processing in Response to Alcohol to Advance Our Understanding of the Pathophysiology and Psychopharmacology of Binge Drinking
Status: Enrolling
Updated: 12/31/1969
An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
Updated: 12/31/1969
Assessing Changes in the Brain Melanocortin System and Sensory Processing in Response to Alcohol to Advance Our Understanding of the Pathophysiology and Psychopharmacology of Binge Drinking
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mindfulness-Based Intervention and Transcranial Direct Current Brain Stimulation to Reduce Heavy Drinking
Updated: 12/31/1969
Mindfulness-Based Intervention and Transcranial Direct Current Brain Stimulation to Reduce Heavy Drinking: Efficacy and Mechanisms of Change
Status: Enrolling
Updated: 12/31/1969
Mindfulness-Based Intervention and Transcranial Direct Current Brain Stimulation to Reduce Heavy Drinking
Updated: 12/31/1969
Mindfulness-Based Intervention and Transcranial Direct Current Brain Stimulation to Reduce Heavy Drinking: Efficacy and Mechanisms of Change
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
NeoSync TMS Treatment for Bipolar I Depression
Updated: 12/31/1969
Evaluation of NeoSync EEG Synchronized TMS For the Treatment of Major Depressive Episode in Bipolar Disorder and Associated Neural Response: An Open Label Trial
Status: Enrolling
Updated: 12/31/1969
NeoSync TMS Treatment for Bipolar I Depression
Updated: 12/31/1969
Evaluation of NeoSync EEG Synchronized TMS For the Treatment of Major Depressive Episode in Bipolar Disorder and Associated Neural Response: An Open Label Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol Dependence
Updated: 12/31/1969
Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol Dependence
Status: Enrolling
Updated: 12/31/1969
Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol Dependence
Updated: 12/31/1969
Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol Dependence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism
Updated: 12/31/1969
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism
Status: Enrolling
Updated: 12/31/1969
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism
Updated: 12/31/1969
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Women's Treatment and Early Recovery
Updated: 12/31/1969
Neural Mechanisms in Women's Treatment and Early Recovery
Status: Enrolling
Updated: 12/31/1969
Women's Treatment and Early Recovery
Updated: 12/31/1969
Neural Mechanisms in Women's Treatment and Early Recovery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mentored Research on Improving Alcohol Brief Interventions in Medical Settings
Updated: 12/31/1969
Mentored Research on Improving Alcohol Brief Interventions in Medical Settings
Status: Enrolling
Updated: 12/31/1969
Mentored Research on Improving Alcohol Brief Interventions in Medical Settings
Updated: 12/31/1969
Mentored Research on Improving Alcohol Brief Interventions in Medical Settings
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Updated: 12/31/1969
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
Updated: 12/31/1969
Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
Status: Enrolling
Updated: 12/31/1969
Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
Updated: 12/31/1969
Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial of AVL-3288 in Schizophrenia Patients
Updated: 12/31/1969
Double Blind, Two Dose, Cross-over Clinical Trial of the Positive Allosteric Modulator at the alpha7 Nicotinic Cholinergic Receptor AVL-3288 in Schizophrenia Patients
Status: Enrolling
Updated: 12/31/1969
Clinical Trial of AVL-3288 in Schizophrenia Patients
Updated: 12/31/1969
Double Blind, Two Dose, Cross-over Clinical Trial of the Positive Allosteric Modulator at the alpha7 Nicotinic Cholinergic Receptor AVL-3288 in Schizophrenia Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Estradiol and Fear Extinction in Anorexia Nervosa (AN)
Updated: 12/31/1969
Estradiol and Fear Extinction for Calorie-Dense Foods in Weight Restored Adult Women With Anorexia Nervosa (AN)
Status: Enrolling
Updated: 12/31/1969
Estradiol and Fear Extinction in Anorexia Nervosa (AN)
Updated: 12/31/1969
Estradiol and Fear Extinction for Calorie-Dense Foods in Weight Restored Adult Women With Anorexia Nervosa (AN)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Feasibility and Efficacy of an Extremely Brief Mindfulness Practice
Updated: 12/31/1969
The Feasibility and Efficacy of an Extremely Brief Mindfulness Practice
Status: Enrolling
Updated: 12/31/1969
The Feasibility and Efficacy of an Extremely Brief Mindfulness Practice
Updated: 12/31/1969
The Feasibility and Efficacy of an Extremely Brief Mindfulness Practice
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 2
Updated: 12/31/1969
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 2
Status: Enrolling
Updated: 12/31/1969
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 2
Updated: 12/31/1969
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 2
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 2
Updated: 12/31/1969
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 2
Status: Enrolling
Updated: 12/31/1969
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 2
Updated: 12/31/1969
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 2
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)
Updated: 12/31/1969
A Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials